Distribution patterns of dendritic cells and T cells in diffuse large B-cell lymphomas correlate with prognoses

Clinical Cancer Research

Volumn 13, Issue 22, 2007, Pages 6666-6672

  Chang, Kung Chao ^a,e   Huang, Guan Cheng ^b   Jones, Dan ^d   Lin, Ya Hui ^c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RO ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANZYME B; HLA DR ANTIGEN; PREDNISONE; PROTEIN S 100; T6 ANTIGEN; VINCRISTINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CANCER IMMUNOTHERAPY; CELL COUNT; CELL DENSITY; CELL INFILTRATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD1; DENDRITIC CELLS; FEMALE; HLA-DR ANTIGENS; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; T-LYMPHOCYTES;

EID: 36749013021     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0504     Document Type: Article

References (41)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARCPress; 2001. p.171-4.
2. Coiffier B. Immunochemotherapy: the new standard in aggressive non-Hodgkin's lymphoma in the elderly. Semin Oncol 2003;30:21-7.
3. Janeway CA, Jr., Travers P, Walport M, Shlomchik MJ, editors. Immunobiology: the immune system in health and disease. 6th ed. New York: Garland Science Publishing; 2005. p. 630-42.
4. Timmerman JM, Czerwinski DK, Davis TA, et al. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood 2002;99:1517-26.
5. Chen HW, Lee YP, Chung YF, et al. Inducing long-term survival with lasting anti-tumor immunity in treating B cell lymphoma by a combined dendritic cell-based and hydrodynamic plasmid-encoding IL-12 gene therapy. Int Immunol 2003;15:427-35.
6. Kwak LW. Translational development of active immunotherapy for hematologic malignancies. Semin Oncol 2003;30:17-22.
7. Brentjens RJ, Latouche JB, Santos E, et al. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat Med 2003;9:279-86.
8. Miller RA, Hart S, Samoszuk M, et al. Shared idiotypes expressed by human B-cell lymphomas. N Engl J Med 1989;321:851-7.
9. Riemersma SA, Jordanova ES, Schop RF, et al. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in Bcell lymphomas arising in immune-privileged sites. Blood 2000;96:3569-77.
10. Rimsza LM, Roberts RA, Miller TP, et al. Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. Blood 2004;103:4251-8.
11. Fong L, Engleman EG. Dendritic cells in cancer immunotherapy. Annu Rev Immunol 2000;18:245-73.
12. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
13. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004;5:1219-26.
14. Liu YJ, Kanzler H, Soumelis V, Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol 2001;2:585-9.
15. Vermi W, Bonecchi R, Facchetti F, et al. Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas. J Pathol 2003;200:255-68.
16. Ansell SM, Stenson M, Habermann TM, Jelinek DF, Witzig TE. CD4+ T-cell immune response to large Bcell non-Hodgkin's lymphoma predicts patient outcome. J Clin Oncol 2001;19:720-6.
17. + T-cell responses. Blood 2005;105:3596-604.
18. Pages F, Berger A, Camus M, et al. Effector memory Tcells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005;353:2654-66.
19. Chang KC, Huang GC, Jones D, Tsao CJ, Lee JY, Su IJ. Distribution and prognosis of WHO lymphoma subtypes in Taiwan reveals a low incidence of germinal center derived tumors. Leuk Lymphoma 2004;45:1375-84.
20. Krol AD, le Cessie S, Snijder S, Kluin-Nelemans JC, Kluin PM, Noordijk EM. Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol 2003;14:131-9.
21. Bell D, Chomarat P, Broyles D, et al. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 1999;190:1417-26.
22. Fiore F, Von Bergwelt-Baildon MS, Drebber U, et al. Dendritic cells are significantly reduced in non-Hodgkin's lymphoma and express less CCR7 and CD62L. Leuk Lymphoma 2006;47:613-22.
23. Steinm an RM, Pack M, Inaba K. Dendritic cells in the T-cell areas of lymphoid organs. Immunol Rev 1997;156:25-37.
24. Takahashi K, Asagoe K, Zaishun J, et al. Heterogeneity of dendritic cells in human superficial lymph node: in vitro maturation of immature dendritic cells into mature or activated interdigitating reticulum cells. Am J Pathol 1998;153:745-55.
25. Chang KC, Khen NT, Jones D, Su IJ. Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype. Hum Pathol 2005;36:747-55.
26. Tsai ST, Jin YT, Wu TC. Synthesis of PCR-derived, digoxigenin-labeled DNA probes for in situ detection of Epstein-Barr early RNAs in Epstein-Barr virus-infected cells. J Virol Methods 1995;54:67-74.
27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
28. Gehan EA. A generalized two-sample Wilcoxon test for doubly censored data. Biometrika 1965;52:650-3.
29. Cox DR. Regression models and life tables. JRoyal Stat Soc B 1972;B34:187-220.
30. Hsu FJ, Kwak L, Campbell M, et al. Clinical trials of idiotype-specific vaccine in B-cell lymphomas. Ann N Y Acad Sci 1993;690:385-7.
31. Syrengelas AD, Chen TT, Levy R. DNA immunization induces protective immunity against B-cell lymphoma. Nat Med 1996;2:1038-41.
32. Hsu FJ, Benike C, Fagnoni F, et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996;2:52-8.
33. Gattringer C, Huber H, Radaszkiewicz T, Pfaller W, Braunsteiner H. Imbalance of helper and suppressor T lymphocytes in malignant non-Hodgkin lymphomas: an in situ morphometric analysis. Int J Cancer 1984;33:751-7.
34. Monti S, Savage KJ, Kutok JL, et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005;105:1851-61.
35. Achten R, Verhoef G, Vanuytsel L, DeWolf-Peeters C. T-cell/histiocyte- rich large B-cell lymphoma: a distinct clinicopathologic entity. J Clin Oncol 2002;20:1269-77.
36. Treilleux I, Blay JY, Bendriss-Verm are N, et al. Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res 2004;10:7466-74.
37. Sandel MH, Dadabayev AR, Menon AG, et al. Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization. Clin Cancer Res 2005;11:2576-82.
38. Kalinski P, Schuitemaker JH, Hilkens CM, Wierenga EA, Kapsenberg ML. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-γ and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J Immunol 1999;162:3231-6.
39. Langenkamp A, Messi M, Lanzavecchia A, Sallusto F. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol 2000;1:311-6.
40. + TNFα. J Exp Med 1996;184:695-706.
41. Idoyaga J, Moreno J, Bonifaz L. Tumor cells prevent mouse dendritic cell maturation induced by TLR ligands. Cancer Immunol Immunother 2007;56:1237-50.